current clinical trials for Depression and Panic Disorder
Currently Recruiting
The EMBRACE Trial
About the Study
The EMBRACE trial is exploring a different kind of investigational study drug to learn how effective it might be at reducing
symptoms of MDD. The investigational study drug will be combined with several psychological support sessions with a licensed therapist who has training in EMBARK, a psychological support model for MDD. You would also continue taking your current antidepressant drug. It is hoped that the investigational study drug given with psychological support may help people reach deeper into their thoughts to promote healing and potentially treat MDD.
Who can take part?
We are enrolling people aged 18 to 85 who:
- Have been diagnosed with MDD and don’t feel their current medication is treating their depression well enough
- Have been taking a single antidepressant drug at a consistent dose for at least 4 weeks
- Do not have any psychotic disorder, such as schizophrenia or bipolar disorder
- There are other requirements to join this study.
Study commitments:
- About 4 1/2 months
- 8 clinic appointments
- 8 video call appointments
- 9 psychological support sessions by video call or at the clinic
Interested to participate in a clinical trial?
Please contact the Research Team with your preferred method.
Neurocentrix Head Office
- Level 2, 551 Swanston Street, Carlton VIC 3053
- research@neurocentrix.com.au
- 03 9546 0009
- 03 9959 8375
Request an appointment or send an enquiry
Fields marked with * (asterisk) are required.
By entering your contact details, you agree to receive information from NeuroCentrix in the future that we believe may be relevant to you. Naturally, you can unsubscribe any time.